Report
Clément Bassat ...
  • Gaetan Calabro
  • Mohamed Kaabouni
  • Nicolas Delmas
  • Nicolas Royot

La Matinale - 31-03-2023

LA VALEUR DU JOUR :
BIOSENIC : Biosenic étend son horizon de trésorerie à mai 2023 – Acheter (1), obj. 0.52€ Cours: 0.10€ au 30/03/23
MAAT PHARMA : De nombreux jalons cliniques validés en 2022 – Acheter (1), obj. 16.0€ Cours: 10.0€ au 30/03/23
METABOLIC EXPLORER : Exercice 2022 très dégradé comme attendu – Conserver (3), obj. 1.39€ Cours: 1.24€ au 30/03/23
PHERECYDES PHARMA : Une année de structuration – Acheter (1), obj. 5.50€ Cours: 2.45€ au 30/03/23
WINFARM : Se tourner vers l'avenir – Acheter (1), obj. 24.2€ Cours: 22.3€ au 30/03/23
ENERGIES RENOUVELABLES : Un objectif ambitieux à 42,5% de renouvelable en Europe
ET AUSSI : VRANKEM POMMERY, XILAM, VERIMATRIX…
Underlyings
Bone Therapeutics SA

Bone Therapeutics is a biotechnology company with an advanced clinical pipeline of cell products for orthopaedic conditions and bone diseases (two Phase II/III and three Phase I/II clinical studies). These areas are characterized by high unmet medical needs due to the lack of efficacious and safe, non-invasive, treatments. Co. has two products in clinical trials, its allogeneic bone cell therapy product, ALLOB®, and its autologous bone cell therapy product, PREOB®. Co. is also conducting preclinical research on next generation products, such as combined cell-matrix products for large bone defects and maxillofacial.

MAAT PHARMA SA

METabolic EXplorer SA

Metabolic Explorer SA. Metabolic Explorer SA is a France-based biological chemistry company that specializes in the development of bioprocesses for the production of chemical compounds used in a range of products, such as textile fibers, paints, solvents, animal feed supplements and adhesives, among others. Metabolic Explorer SA offers chemicals, such as Glycolic acid, L-Methionine, MPG (1.2 Propanediol) and PDO (1.3 Propanediol). The Company markets its products mainly for three families of industrialists: Manufacturers of agro-resources, Existing producers of chemical compounds and Manufacturers employing chemical compounds. In addition, the Company is engaged in the research and development works and runs its own laboratory to develop micro-organisms.

Pherecydes Pharma

Provider
Portzamparc Sponsored
Portzamparc Sponsored

​Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.

Analysts
Clément Bassat

Gaetan Calabro

Mohamed Kaabouni

Nicolas Delmas

Nicolas Royot

Other Reports on these Companies
Other Reports from Portzamparc Sponsored

ResearchPool Subscriptions

Get the most out of your insights

Get in touch